Search
for
Sort by
Research 421–450 of 1000+
- Cicatricial alopecia
- Alopecia as a rare but distinct manifestation of pemphigus vulgaris
- Proposing a Simpler Classification of Telogen Effluvium
- Evaluation of hair loss
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Immediate and Delayed Complications of Dexamethasone Cyclophosphamide Pulse (DCP) Therapy
- A comparison of the culture and growth of dermal papilla cells from hair follicles from non-balding and balding (androgenetic alopecia) scalp
- DERMATOLOGIC DISEASES AND PROBLEMS OF WOMEN THROUGHOUT THE LIFE CYCLE
- Minoxidil overdose with ecg changes: Case report and review
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- Obsessive-compulsive disorder in dermatology
- Non-hemorrhage-related adverse effects of rivaroxaban
- Hair loss
- Is there a role for 5α‐reductase inhibitors in transgender individuals?
- Diseases that turn African hair silky
- Molecular Genetics of Alopecias
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- Testosterone Treatment in Women – An Overview
- Telogen effluvium, Beau lines, and acral peeling associated with COVID-19 infection
- Two mouse mutations mapped to chromosome 11 with differing morphologies but similar progressive inflammatory alopecia
- Indian Gooseberry (<i>Emblica officinalis</i>Gaertn.)
- Hyperadrenocorticism in Ferrets
- Alopecia and hirsutism*
- Proxalutamide Reduction of Mortality Rate in Hospitalized COVID-19 Patients Depends on Treatment Duration – an Exploratory Analysis of the Proxa-Rescue AndroCoV Trial
- Disease severity scoring systems in dermatology
- Interpretation of Laboratory Data and General Physical Examination by Pharmacists
- Androgenetic alopecia – is contact dermatitis an accelerating factor?
- A Phase 1 Study to Investigate the Effects of Cortexolone 17α‐Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity
- Management of Toxicities of Targeted Therapies
- CONTRACEPTION AND THE SKIN